Alba Casta Pharma Solutions, India possesses brand SugrLite, which is capable of bringing disruption in FMCG sector. Combined sale potential of SugrLite brand is USD $8-10 billions per annum. AlCaS invites interested parties to invest as seed funds in this exciting opportunity. Discuss these opportunities at arvind.mittal@albacasta.co.in

1. Alba Casta Pharma Solutions, India
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.
Office 289-A
2nd Floor, B-Block,
Motia Plaza Business Center,
Pinjore Nalagarh National Highway 21-A
Baddi,
Solan, Himachal Pradesh, INDIA-173205
+91 9417565430, +91 8360447094
Email: albacasta.pharma@gmail.com;
albacasta.india@gmail.com

2.  Established in March 2015, It’s a partnership
firm registered with Department of Industry,
Baddi, Himachal Pradesh.
 Authorized to carry out trade (including
foreign trade) and manufacturing.
 GSTN No: 02ABBFA9764B1ZU
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.
Alba Casta Pharma Solutions, India

3. Business Activities:
 Artificial Sweetener: The firm holds own
Registered brand name SugrLite® (Trade Mark
No. 3110111) approved by Registrar of
Trademark, GoI.
 Pharmaceutical consulting.
 We intend to enter in specialized food sector
for diabetic population (FMCG) which has high
business potential.
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.
Alba Casta Pharma Solutions, India

4.  The firm has coined an innovative idea to create a new group
of FMCG sector comprising of diabetic population in the
market.
 A disruptive idea so that this huge population (529 Million)
can be targeted by a single but appealing brand.
 There is a huge potential of growth in this FMCG sector which
shall be driven by increasing diabetics incidences and greater
awareness of health in younger generation.
 No such idea in the market exists and there are very few
players/brands in domestic and international markets.
 Subsequently, the firm coined the name “SUGRLITE” applied
for trademark registration and granted Certificate of
Registration.
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.
SugrLite An Innovative Idea

5. World Diabetes Scenario
According to Diabetes Atlas 8th Edition, 2017,
about 427 million people worldwide, are
suffering from diabetes and this number is
expected to touch 629 million by 2045.
In India alone, 74 million adults have diabetes.
In addition to this 130 million are pre-diabetic,
thus making a potential target population of
around 200 million in India itself.
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.

6. © Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.
The following characteristics of trademark SUGRLITE are apparent:
 It is unique and distinctive vs. its competitors, viz,. Sugar FreeTM,
Splenda® and Equal®.
 Since it is easy to spell, remember and contextual in nature, ie.,
easily conveys the idea and purpose of product(s). Therefore, it is
significant and encouraging to the niche market,
 As the name suggests, it will be identified across the major
geographic markets breaking the language barriers. Even a less
literate person will be able to understand the purpose of the
product(s).
 With its uniqueness, it conveys the idea of original product(s).

7. Alba Casta Pharma Solutions, India
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.

8. Other Sweetener Brands
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.

9. Sweetener Business
 The sugar substitutes market is estimated to be valued at USD 13.26
Billion in 2015 and is projected to reach USD 16.53 Billion by 2020.
(https://www.marketsandmarkets.com/Market-Reports/sugar-substitute-market-
1134.html?gclid=EAIaIQobChMI4rWW34773QIVwhqPCh19QgYWEAAYASAAEgJ-R_D_BwE)
 The combined business of branded sweeteners in India is around
150 cr with CAGR of double digit. Major business is done by Zydus
Wellness with brand name Sugar FreeTM.
 Profit Margin is 80-90%.
 Great export potential.
 Alba Casta has clear title Trademark No 3110111. (Biggest
advantage).
 Rs 50-60 cr sweetener business can be achieved in next 5 Years
through domestic as well as export.
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.

10. Brand Positioning
Sweeteners
 SugrLite® : Alba Casta Pharma(www.sugrlite.com)
 Sugar FreeTM : Zydus Wellness(www.sugarfree.com)
 Equal® NutraSweet®, Canderel® :Merisant USA
 Splenda® : Tate & Lyle UK(www.splenda.com)
 Kaloree1 Mankind Pharma.
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.

11. Utilization of SugrLite in FMCG
SugrLite® name can be utilized to work as ‘Umbrella Brand’ as well as ‘Brand
Extension’ and shall cover, including but not limited to:
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.
Products Examples
1 Sweeteners (Saccharine, Aspartame,
Sucralose, Stevia, Acesulfame K, Neotame,
Erythritol or any other future incoming
artificial/natural/semi-synthetic
sweeteners)
SugrLite Classic, Gold,
naturals etc
2 Multigrain or diabetic care flour, Bread SugrLite Multigrain Flour
3 Brown rice & par boiled rice, Pulses SugrLite Brown Rice
4 Fruit Juices with label ‘No Added Sugar’ SugrLite Apple, Mixed
Fruit..
5 Agriculture produce Low Sugar Potato SugrLite Potato
6 Wheat Porridge SugrLite Porridge

12. Utilization of SugrLite in FMCG
Products Examples
7 Club Soda SugrLite Club Soda
8 Beverages (carbonated & non-
carbonated, e.g., equivalent to Coke®
Zero & energy drinks)
SugrLite Orange, Lime, Cola
etc
9 Sweetened Milk & Milk Products SugrLite Milk, lassi
10 Noodles SugrLite Noodles
11 Biscuits & Cookies SugrLite Biscuts
12 Ice Cream without sugar SugrLite Butter Scotch
13 Cakes Chocolates & Confectionaries SugrLite Chocolate
14 Cooking oils (Almond, Avocado,
Hazelnut, Olive, Canola) meant for
diabetics
SugrLite Extra Virgin Olive
Oil
15 Any food having low sugar content or
low G.I. index
SugrLite ......
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.

13. Annual Sale Projection of SugrLite®
As per the estimate, if 200 million people out
of 529 million (Source International Diabetic
Federation) spends USD $40-50 per annum on
SugrLite products, then it has potential to
generate sale USD $8-10 Billion annually.
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.

14. Utilization of SugrLite in FMCG
Each Project is a separate entity
and shall be negotiated
separately.
© Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.

15. © Copyright 2018 Alba Casta Pharma Solutions, India. All rights are reserved.